The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Trovagene, Inc. - Precision Medicine Biotechnology Company Developing Oncology Therapeutics for Cancer Care

SNNLive spoke with Bill Welch, CEO of Trovagene, Inc. (NASDAQ: TROV) at the LD Micro Invitational 2017 in Bel Air, CA.

Share With

Wednesday, July 26, 2017

   

© 2018 Stock News Now